Showing results (1091-1100 of 1,611) with videos related to

Sort By:
Pageof 162
JAMA Oncology|May 1, 2018
Estimation of Future Cancer Burden Among Rescue and Recovery Workers Exposed to the World Trade Center DisasterAnkura Singh, Rachel Zeig-Owens, William Moir, et al.
JAMA Oncology|May 1, 2018
Estimation of the Percentage of US Patients With Cancer Who Benefit From Genome-Driven OncologyJohn Marquart, Emerson Y Chen, Vinay Prasad
JAMA Oncology|May 1, 2018
Multiple Myeloma and Its Precursor Disease Among Firefighters Exposed to the World Trade Center DisasterOla Landgren, Rachel Zeig-Owens, Orsolya Giricz, et al.
JAMA Oncology|April 12, 2019
Safety and Feasibility of Using Magnetic Resonance Imaging Criteria to Identify Patients With "Good Prognosis" Rectal Cancer Eligible for Primary Surgery: The Phase 2 Nonrandomized QuickSilver Clinical TrialErin D Kennedy, Marko Simunovic, Kartik Jhaveri, et al.
JAMA Oncology|June 14, 2019
Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian CarcinomaPanagiotis A Konstantinopoulos, Steven Waggoner, Gregory A Vidal, et al.
JAMA Oncology|August 21, 2025
Impact of a Weight Loss Intervention on 1-Year Weight Change in Women With Stage II/III Breast Cancer: Secondary Analysis of the Breast Cancer Weight Loss (BWEL) TrialJennifer A Ligibel, Karla V Ballman, Linda McCall, et al.
JAMA Oncology|March 2, 2023
State Variation in Racial and Ethnic Disparities in Incidence of Triple-Negative Breast Cancer Among US WomenHyuna Sung, Daniel Wiese, Ismail Jatoi, et al.
JAMA Oncology|March 17, 2023
Pembrolizumab Added to Ifosfamide, Carboplatin, and Etoposide Chemotherapy for Relapsed or Refractory Classic Hodgkin Lymphoma: A Multi-institutional Phase 2 Investigator-Initiated Nonrandomized Clinical TrialLocke J Bryan, Carla Casulo, Pamela B Allen, et al.
JAMA Oncology|November 10, 2022
Cost-effectiveness of Prostate Cancer Screening Using Magnetic Resonance Imaging or Standard Biopsy Based on the STHLM3-MRI StudyShuang Hao, Andrea Discacciati, Martin Eklund, et al.
JAMA Oncology|March 9, 2023
Regorafenib, Ipilimumab, and Nivolumab for Patients With Microsatellite Stable Colorectal Cancer and Disease Progression With Prior Chemotherapy: A Phase 1 Nonrandomized Clinical TrialMarwan Fakih, Jaideep Sandhu, Dean Lim, et al.
Pageof 162